Meet the Team

Discover more about the team behind this award-winning, Cambridge University spin-out company, and the people involved in helping bring its exciting autoimmune prognostic tests to the customers and patients that need them most.

The PredictImmune team features a number of highly qualified research and commercial specialists with many years of experience between them. To find out more about PredictImmune’s team of specialists, and to see the value and professionalism they bring to all of their research, please read the team bios below.

Professor Kenneth Smith

Professor Kenneth Smith

BMedSci, MBBS, PhD, MA, FRCP, FRCPA, FRACP, FHEA, FMedSci

More about Kenneth

Professor Ken Smith is Professor of Medicine and Head of the Department of Medicine at the University of Cambridge. He trained in nephrology (FRACP, FRCP) and clinical immunology (FRCPA) and completed a PhD at the WEHI in Melbourne. His laboratory runs a translational programme in autoimmune disease (particularly inflammatory bowel disease, vasculitis and SLE) that has led to the discovery of a novel prognosis-predicting biomarker currently in clinical trials and the identification of genes and pathways involved in disease pathogenesis.
Andrew P Sandham

Andrew P Sandham

Chairman

More about Andrew

Andrew has more than 30 years’ experience in co-founding and building start-up businesses in the biotechnology sector in the UK and US. He has served in chairman, non-executive and executive roles with UK and US biotech start-up companies, including Cantab Pharmaceuticals, Hexagen, Signature Bioscience, Novacta, Ionix Pharmaceuticals, NeurAxon, Syntaxin, Synosia, Kymab, Bicycle Therapeutics, 14M Genomics and PredictImmune. He has also worked within venture capital firms Abingworth and Syncona and currently serves as a director of Plant Bioscience (PBL) and is deputy chairman of the Cambridge Enterprise Investment Committee.
Eoin McKinney BA, MBChB, MRCP, PhD

Eoin McKinney BA, MBChB, MRCP, PhD

Chief Scientific Officer

More about Eoin

Eoin is a Wellcome-Beit intermediate Research Fellow in the Department of Medicine at the University of Cambridge and an honorary consultant in nephrology and transplantation in Cambridge University NHS hospitals Foundation Trust. He obtained a first-class degree in pre-clinical medicine from Keble College, Oxford University in 1999 and graduated in clinical medicine with honours from Edinburgh University in 2002. His primary interest is the use of systems immunology approaches to translate high throughput analyses of autoimmune disease datasets into clinical practice.
Paul Lyons BSc, PhD

Paul Lyons BSc, PhD

VP Platform Delivery

More about Paul

Paul is a Principal Research Associate in the Department of Medicine at the University of Cambridge. He has over 25 years of experience in molecular and cellular biology including Senior Scientist positions in the Dept. Medical Genetics, University of Cambridge, Dept. Surgery, University of Oxford and the Rosalind Franklin Centre for Genomics Research. His primary research interest is the application of high throughput genomic approaches to better understand the genetic and molecular basis of autoimmune disease.